Diffraction Methods in Drug Discovery and Development

X-ray crystallography remains the cornerstone of structural determination for both proteins and small molecules within the pharmaceutical industry.

This half-day symposium will convene leading experts from academia and industry to explore the pivotal role of X-ray crystallography in advancing pharmaceutical research and development.

Presentations will encompass protein structure determination, structure-based drug design, and small molecule crystallography, fostering a dynamic exchange of ideas between structural biologists and chemists.

The program will also include ample networking opportunities, allowing attendees to connect over coffee and discuss the latest advancements in the field.

Additionally, there will be the opportunity to visit the X-ray crystallography facility at The Francis Crick Institute equipped with a D8 VENTURE METALJET system.

Venue

The Symposium will be hosted by The Francis Crick Research Institute.    The Institute is located a few minutes’ walk from St. Pancras International Railway station in central London.  You can conveniently reach the venue from across northwest Europe.

For directions see: https://www.crick.ac.uk/about-us/visit-us

Registration for this event has been closed.

Mladen Vinkovic, Ph.D.
Director at Molecular Sciences group
Astex Pharmaceuticals, Cambridge, UK

Marianne Schimpl, Ph.D.
Associate Principal Scientist
AstraZeneca Cambridge, UK

Jim Spencer, Ph.D.
Professor of Bacteriology
University of Bristol

Chun-wa Chung, Ph.D.
Executive Director & Global Head Structural and Biophysical Sciences
GlaxoSmithKline, Stevenage, UK

Arnaud Basle, Ph.D.
Structural Biology Facility Manager
Newcastle University Biosciences Institute, UK

Jennifer Miles, Ph.D.
Research Fellow in Structural Biology
University of Leeds